- Joined
- Oct 9, 2019
- Messages
- 288
- Reaction score
- -1
- Points
- 28
- Age
- 43
PAL-GHK 10mg
PAL-GHK is also known as palmitoyl tripeptide-1 and is a small copper-binding peptide made up of three amino acids linked to a palmitate molecule. GHK was first discovered in human plasma and was found to be at significantly higher concentrations in the plasma of young people than of old people; linking the peptide to aging.
The peptide has a wide range of biological functions and has been found to regulate a large number of proteins in the human body, many of which are linked to health-promoting abilities. The genes stimulated by PAL-GHK essentially reset cells to a younger, healthier state.
GHK has been widely used as a gel or cream in human studies for skin healing without adverse effects. Since the GHK peptide is naturally present in human serum, it is likely that PAL-GHK can be administered at the recommended dose with little or no side effects.
GHK has a half-life of approximately 1 hour after injection and has been administered to animals at doses of 0,5 mcg / kg, which is equivalent to approximately 2 mcg / kg if designed for human use. The suggested dose is therefore 1,5 mg per day injected subcutaneously or intramuscularly for effects all over the body
PAL-GHK is also known as palmitoyl tripeptide-1 and is a small copper-binding peptide made up of three amino acids linked to a palmitate molecule. GHK was first discovered in human plasma and was found to be at significantly higher concentrations in the plasma of young people than of old people; linking the peptide to aging.
The peptide has a wide range of biological functions and has been found to regulate a large number of proteins in the human body, many of which are linked to health-promoting abilities. The genes stimulated by PAL-GHK essentially reset cells to a younger, healthier state.
GHK has been widely used as a gel or cream in human studies for skin healing without adverse effects. Since the GHK peptide is naturally present in human serum, it is likely that PAL-GHK can be administered at the recommended dose with little or no side effects.
GHK has a half-life of approximately 1 hour after injection and has been administered to animals at doses of 0,5 mcg / kg, which is equivalent to approximately 2 mcg / kg if designed for human use. The suggested dose is therefore 1,5 mg per day injected subcutaneously or intramuscularly for effects all over the body
